{"id":"https://openalex.org/W2591350607","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","title":"Interim results of a phase 1b/2a study evaluating the nano pharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC).","display_name":"Interim results of a phase 1b/2a study evaluating the nano pharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC).","publication_year":2014,"publication_date":"2014-02-01","ids":{"openalex":"https://openalex.org/W2591350607","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","mag":"2591350607"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.4_suppl.412","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053933311","display_name":"Stephen J. O\u2019Keefe","orcid":"https://orcid.org/0000-0003-4422-3145","observed_orcids":["https://orcid.org/0000-0003-4422-3145"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Michael Keefe","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026614969","display_name":"Daniel F. Heitjan","orcid":"https://orcid.org/0000-0002-1527-4472","observed_orcids":["https://orcid.org/0000-0002-1527-4472"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Heitjan","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038547603","display_name":"Meliessa Hennessey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162229","display_name":"Cerulean Pharma (United States)","ror":"https://ror.org/03xrs4d06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162229"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meliessa Hennessey","raw_affiliation_strings":["Cerulean Pharma, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerulean Pharma, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210162229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113846718","display_name":"Janelle Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janelle Robinson","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072312661","display_name":"Kristine Mykulowicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristine Mykulowicz","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013892238","display_name":"Amy Marshall","orcid":"https://orcid.org/0000-0001-6842-4641","observed_orcids":["https://orcid.org/0000-0001-6842-4641"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Marshall","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007652011","display_name":"\u00d6rvar Gunnarsson","orcid":"https://orcid.org/0000-0001-8581-2769","observed_orcids":["https://orcid.org/0000-0001-8581-2769"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Orvar Gunnarsson","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055266545","display_name":"Ronac Mamtani","orcid":"https://orcid.org/0000-0002-8267-5356","observed_orcids":["https://orcid.org/0000-0002-8267-5356"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronac Mamtani","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035439869","display_name":"David J. Vaughn","orcid":"https://orcid.org/0000-0002-7319-7719","observed_orcids":["https://orcid.org/0000-0002-7319-7719"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Vaughn","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044979250","display_name":"Jean H. Hoffman-Censits","orcid":"https://orcid.org/0000-0002-6970-6509","observed_orcids":["https://orcid.org/0000-0002-6970-6509"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean H. Hoffman-Censits","raw_affiliation_strings":["Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072490052","display_name":"Katherine L. Nathanson","orcid":"https://orcid.org/0000-0002-6740-0901","observed_orcids":["https://orcid.org/0000-0002-6740-0901"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine L. Nathanson","raw_affiliation_strings":["Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091337350","display_name":"Priti Lal","orcid":"https://orcid.org/0000-0003-2193-9968","observed_orcids":["https://orcid.org/0000-0003-2193-9968"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priti Lal","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074054064","display_name":"Daniel A. Pryma","orcid":"https://orcid.org/0000-0001-8978-4419","observed_orcids":["https://orcid.org/0000-0001-8978-4419"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Pryma","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068754903","display_name":"Scott D. Eliasof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162229","display_name":"Cerulean Pharma (United States)","ror":"https://ror.org/03xrs4d06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162229"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Eliasof","raw_affiliation_strings":["Cerulean Pharma, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerulean Pharma, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210162229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003527979","display_name":"Edward Graeme Garmey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162229","display_name":"Cerulean Pharma (United States)","ror":"https://ror.org/03xrs4d06","country_code":"US","type":"company","lineage":["https://openalex.org/I4210162229"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Graeme Garmey","raw_affiliation_strings":["Cerulean Pharma, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerulean Pharma, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210162229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110382646","display_name":"Roger B. Cohen","orcid":"https://orcid.org/0009-0004-7423-2653","observed_orcids":["https://orcid.org/0009-0004-7423-2653"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger B. Cohen","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046123003","display_name":"Naomi Balzer Haas","orcid":"https://orcid.org/0000-0001-8907-7968","observed_orcids":["https://orcid.org/0000-0001-8907-7968"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naomi B. Haas","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"4_suppl","first_page":"412","last_page":"412"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crlx101","display_name":"CRLX101","score":0.9959999918937683},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.7009999752044678},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.6650000214576721},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/hif-inhibition","display_name":"HIF inhibition","score":0.7120000123977661},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7170000076293945},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6010000109672546},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8289999961853027},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.6240000128746033},{"id":"https://openalex.org/keywords/dual-inhibition","display_name":"dual inhibition","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9281821250915527},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6353930234909058},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.544601321220398},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5418740510940552},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4932965636253357},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.46687597036361694},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.42413944005966187},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2660614252090454},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.4_suppl.412","doi":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.4_suppl.412","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2071816310","https://openalex.org/W2883938286","https://openalex.org/W2604664953","https://openalex.org/W2417009030","https://openalex.org/W2754843139","https://openalex.org/W2603993575","https://openalex.org/W1971927952","https://openalex.org/W2316448599","https://openalex.org/W1991283648","https://openalex.org/W2908295371"],"abstract_inverted_index":{"412":[0],"Background:":[1],"VHL":[2],"is":[3,303,324],"inactivated":[4],"in":[5,27,32,55,66,74,127,296],"most":[6],"clear":[7,171],"cell":[8],"RCC":[9],"(ccRCC)":[10],"tumors":[11],"giving":[12],"rise":[13],"to":[14,41,58,76,91,103,314,326],"the":[15,67,78,81,88,93,136],"HIF":[16],"hypoxia":[17],"response":[18,260],"program":[19],"and":[20,80,90,118,210,244,274],"tumor":[21],"angiogenesis.":[22],"Antiangiogenic":[23],"therapies":[24,106,181],"are":[25],"active":[26],"ccRCC,":[28],"but":[29],"resistance":[30],"develops":[31],"all":[33,329],"pts.":[34],"Dual":[35],"inhibition":[36],"strategies":[37],"may":[38],"be":[39,291],"needed":[40],"overcome":[42],"resistance.":[43],"CRLX101,":[44],"a":[45,128,257],"novel":[46],"nano":[47],"pharmaceutical":[48],"formulation":[49],"of":[50,69,87,96,121,180,205,213,241,251,307,332],"camptothecin,":[51],"has":[52,245],"been":[53],"shown":[54],"pre-clinical":[56],"models":[57],"target":[59],"HIF.":[60],"We":[61],"combined":[62,199,293],"CRLX101":[63,122,190,289,308],"with":[64,71,100,114,132,200,265,294,298,309,328],"bev":[65,115,295],"treatment":[68],"pts":[70,164,254,269,297,327],"refractory":[72,102,299],"mRCC":[73,101],"order":[75],"determine":[77,92],"safety":[79],"recommended":[82],"phase":[83],"2":[84,112,173,175,203,275],"dose":[85,185],"(RP2D)":[86],"combination,":[89],"therapeutic":[94],"activity":[95],"treatment.":[97],"Methods:":[98],"Pts":[99,138],"conventional":[104],"antiangiogenic":[105],"(all":[107],"subtypes)":[108],"were":[109,139,149,157,165,188,217,222],"treated":[110,140],"every":[111],"weeks":[113,243],"10":[116,163],"mg/kg":[117],"escalating":[119],"doses":[120],"(12":[123],"mg/m2,":[124],"15":[125,304],"mg/m2)":[126,196],"standard":[129,201,310],"3+3":[130],"design":[131],"an":[133],"expansion":[134],"at":[135,191],"RP2D.":[137],"until":[141],"progression,":[142],"death,":[143],"or":[144,225],"prohibitive":[145],"toxicity.":[146],"Adverse":[147],"events":[148],"classified":[150],"using":[151],"CTCAE":[152],"v":[153],"4.0.":[154],"Radiographic":[155],"results":[156,286],"assessed":[158],"by":[159],"RECIST":[160],"v1.1.":[161],"Results:":[162],"enrolled":[166],"on":[167],"study":[168],"\u2013":[169],"6":[170],"cell,":[172],"papillary,":[174],"chromophobe.":[176],"Median":[177],"prior":[178],"number":[179],"was":[182,197,233],"2.":[183,226],"No":[184],"limiting":[186],"toxicities":[187,221],"observed.":[189,218],"its":[192],"single-agent":[193],"RP2D":[194,302],"(15":[195],"safely":[198,292],"bev.":[202,311],"episodes":[204],"grade":[206,214,223],"3":[207,215,250],"non-infectious":[208],"cystitis":[209],"1":[211,224,263],"episode":[212],"hypertension":[216],"All":[219],"other":[220],"The":[227,301],"median":[228],"progression":[229],"free":[230],"survival":[231],"(PFS)":[232],"7.6":[234],"months":[235],"which":[236],"exceeded":[237],"our":[238],"pre-specified":[239],"threshold":[240],"16":[242],"triggered":[246],"2nd":[247],"stage":[248],"accrual.":[249],"9":[252],"evaluable":[253],"(33%)":[255],"achieved":[256],"confirmed":[258],"partial":[259],"(PR)":[261],"including":[262],"patient":[264],"papillary":[266],"mRCC;":[267],"4":[268],"(44%)":[270],"displayed":[271],"stable":[272],"disease,":[273],"had":[276],"progressive":[277],"disease":[278],"as":[279,321],"their":[280],"best":[281],"overall":[282],"response.":[283],"Conclusions:":[284],"Our":[285],"demonstrate":[287],"that":[288,317],"can":[290],"mRCC.":[300,333],"mg/m2":[305],"q2w":[306],"Preliminary":[312],"outcomes":[313],"date":[315],"suggest":[316],"clinical":[318],"benefit,":[319],"manifest":[320],"prolonged":[322],"PFS,":[323],"conferred":[325],"histologic":[330],"subtypes":[331],"Clinical":[334],"trial":[335],"information:":[336],"NCT01625936.":[337]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-03-03T00:00:00"}